Circulating and Tissue Markers in the Longitudinal Management of Breast Cancer Patients
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 353, 47-53
- https://doi.org/10.1007/978-1-4615-2443-4_6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- TPS in Breast Cancer – A Comparative Study with Carcinoembryonic Antigen and CA 15-3Tumor Biology, 1992
- Serum Markers for Primary and Recurrent Breast Cancer: BCM-EIA, CAM 26 and CAM 29Tumor Biology, 1992
- CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancerBritish Journal of Surgery, 1989
- Assessment of serial carcinoembryonic antigen: Determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapyJournal of Surgical Oncology, 1989
- Application of mammary serum antigen assay in the management of breast cancer: A preliminary reportBritish Journal of Surgery, 1988
- CA‐549: A new tumor marker for patients with advanced breast cancerJournal of Clinical Laboratory Analysis, 1988
- Carcinoembryonic antigen in breast cancer. Clinical reviewThe American Journal of Medicine, 1986